Cite

HARVARD Citation

    Burnett, A. et al. (2018). A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial. Leukemia. 32 (12), pp. 2693-2714. [Online]. 
  
Back to record